CS Diagnostics Financials
This page shows CS Diagnostics (CSDX) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of CS Diagnostics's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
CS Diagnostics carries a low D/E ratio of 0.00, meaning only $0.00 of long-term debt for every $1 of shareholders' equity. This conservative leverage earns a score of 100/100, indicating a strong balance sheet with room for future borrowing.
CS Diagnostics generates a 0.0% ROE, indicating limited profit relative to shareholders' investment. This results in a returns score of 11/100.
Key Financial Metrics
Earnings & Revenue
CS Diagnostics reported $761 in net income in fiscal year 2025.
Cash & Balance Sheet
CS Diagnostics held $501 in cash against $0 in long-term debt as of fiscal year 2025.
CS Diagnostics had 137M shares outstanding in fiscal year 2025.
Margins & Returns
CS Diagnostics's ROE was 0.0% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.
Capital Allocation
CSDX Income Statement
| Metric | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|
| Revenue | $23K | N/A | $8K |
| Cost of Revenue | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A |
| R&D Expenses | $0 | N/A | N/A |
| SG&A Expenses | $70 | N/A | $70 |
| Operating Income | -$182 | N/A | $536 |
| Interest Expense | N/A | N/A | N/A |
| Income Tax | N/A | N/A | N/A |
| Net Income | -$182 | N/A | $536 |
| EPS (Diluted) | $0.00 | N/A | $0.00 |
CSDX Balance Sheet
| Metric | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|
| Total Assets | $499.4M0.0% | $499.4M | N/A |
| Current Assets | $31K+6090.2% | $501 | N/A |
| Cash & Equivalents | $13-97.4% | $501-98.8% | $42K |
| Inventory | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A |
| Total Liabilities | $2K+12.7% | $1K | N/A |
| Current Liabilities | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A |
| Total Equity | $499.4M0.0% | $499.4M | N/A |
| Retained Earnings | -$4.7M+0.7% | -$4.8M | N/A |
CSDX Financial Ratios
| Metric | Q3'25 | Q4'24 | Q3'24 |
|---|---|---|---|
| Gross Margin | N/A | N/A | N/A |
| Operating Margin | -0.8% | N/A | 6.7% |
| Net Margin | -0.8% | N/A | 6.7% |
| Return on Equity | 0.0% | N/A | N/A |
| Return on Assets | 0.0% | N/A | N/A |
| Current Ratio | N/A | N/A | N/A |
| Debt-to-Equity | 0.000.0 | 0.00 | N/A |
| FCF Margin | N/A | N/A | N/A |
Similar Companies
Frequently Asked Questions
Is CS Diagnostics profitable?
Yes, CS Diagnostics (CSDX) reported a net income of $761 in fiscal year 2025.
What is CS Diagnostics's return on equity (ROE)?
CS Diagnostics (CSDX) has a return on equity of 0.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What are CS Diagnostics's total assets?
CS Diagnostics (CSDX) had $499.4M in total assets as of fiscal year 2025, including both current and long-term assets.
What is CS Diagnostics's debt-to-equity ratio?
CS Diagnostics (CSDX) had a debt-to-equity ratio of 0.00 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is CS Diagnostics's return on assets (ROA)?
CS Diagnostics (CSDX) had a return on assets of 0.0% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
How financially healthy is CS Diagnostics?
CS Diagnostics (CSDX) scores 19 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.